Boston, MA, United States of America

Antoun Nabhan

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Welt Corp., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antoun Nabhan. Retrieved from https://idiyas.com/inventor/antoun-nabhan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antoun Nabhan: Innovator in Migraine Treatment

Introduction

Antoun Nabhan is a notable inventor based in Boston, MA, who has made significant contributions to the field of migraine treatment. His innovative approach combines technology and medicine to provide effective solutions for patients suffering from migraines.

Latest Patents

Nabhan holds a patent for "Systems and methods for the treatment of symptoms associated with migraines." This patent describes a method that involves executing a prescription digital therapeutic designed to alleviate migraine symptoms. The process includes obtaining data from various sources, generating a migraine forecast prediction, and determining the appropriate dosage of migraine-treating medication for the patient.

Career Highlights

Antoun Nabhan is currently associated with Welt Corp., Ltd., where he applies his expertise in developing advanced therapeutic solutions. His work focuses on integrating digital health technologies with traditional treatment methods to enhance patient outcomes.

Collaborations

Nabhan collaborates with Marguerite Manteau-Rao, contributing to the development of innovative solutions in the healthcare sector.

Conclusion

Antoun Nabhan's work exemplifies the intersection of technology and healthcare, particularly in the treatment of migraines. His contributions are paving the way for more effective and personalized treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…